Insider Transactions in Q4 2025 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2025
|
Raju Prasad Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-25.08%
|
$560,000
$56.11 P/Share
|
|
Dec 18
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
30,000
-11.8%
|
-
|
|
Oct 17
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,895
-16.68%
|
$3,409,965
$67.91 P/Share
|
|
Oct 16
2025
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+24.69%
|
-
|
|
Oct 14
2025
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,076
-1.27%
|
$71,016
$66.6 P/Share
|
|
Oct 14
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,242
-2.03%
|
$279,972
$66.6 P/Share
|
|
Oct 13
2025
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,114
+2.44%
|
-
|
|
Oct 13
2025
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+3.83%
|
-
|